Word: pharma
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...lack of definitive results is a major problem, says Dr. John Amory, who has spearheaded much of the male contraceptive research at the University of Washington. He says the science needs to progress before researchers can blame Big Pharma for dragging its heels. Amory's most recent treatment, a daily testosterone gel combined with a quarterly injection, showed a 90% success rate in trials, but, he says, "if we had a compound that was 99% effective, then the drug companies would be on board, the FDA [Food and Drug Administration] would be on board, and consumers would embrace...
...solid protein. He offered Hillaryesque, do-good details: If we return to the national obesity levels of 1980, it would save $1 trillion in health-care costs! He claimed that the mortgage-lending industry had spent $185 million on lobbying over the past decade, and Big Pharma had spent $1 billion. He gave comprehensive answers about trade, immigration and military procurement. He was detailed but never dull. He was, in fact, quite impressive - another sign that this is a candidate smart and supple enough to grow and adapt - even though the substance was buried by media accounts of his transparent...
...research firm that does R and D with a difference. InnoCentive has built up a network of some 140,000 "problem solvers" around the world - they are science Ph.D.s in Russia and engineers in India and amateur inventors in America. InnoCentive posts "challenges" it receives from client companies - the pharma giant Eli Lilly is a customer - on its website, and the solvers go to work, with a cash reward at stake for the right answer. Not only does the InnoCentive method save on costs by allowing companies to outsource some of their R and D, but it also mines...
...raids, early on Wednesday, were launched from Brussels to investigate whether big drug companies were fixing the market to squeeze out copycat medicines. They included forays on Pfizer, Merck, Bayer Schering Pharma and Roche as well as generic firms such as Teva and Sandoz. Hours later, with almost ironic understatement, the E.U. competition watchdog said it had merely launched a "sector inquiry into pharmaceuticals with unannounced inspections...
...also said she was concerned that pharmaceutical companies may be colluding to cut deals that temporarily sideline generics in return for payoffs. With Europeans spending some €200 billion ($297 billion) a year on pharmaceutical products - an average €400 ($588) for every man, woman and child - Big Pharma has a huge interest ensuring that customers continue paying high prices for their drugs...